Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.12% vs -43.51% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 20.69% vs -88.67% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -21.85% vs -69.64% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 46.15% vs 333.33% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.12% vs -43.51% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 61.46% vs 10.95% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 20.69% vs -88.67% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 139.77% vs 35.77% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -21.85% vs -69.64% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 240.91% vs -1.54% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 46.15% vs 333.33% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -29.63% vs 58.82% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






